ID: ALA424608

Max Phase: Preclinical

Molecular Formula: C21H28N2O6

Molecular Weight: 404.46

Molecule Type: Small molecule

Representations

Canonical SMILES:  C[C@H]([C@@H]1O[C@H]1C[C@H]1CO[C@@H](Cc2nnc(-c3ccccc3)o2)[C@H](O)[C@@H]1O)[C@H](C)O

Standard InChI:  InChI=1S/C21H28N2O6/c1-11(12(2)24)20-16(28-20)8-14-10-27-15(19(26)18(14)25)9-17-22-23-21(29-17)13-6-4-3-5-7-13/h3-7,11-12,14-16,18-20,24-26H,8-10H2,1-2H3/t11-,12-,14-,15-,16-,18+,19-,20-/m0/s1

Standard InChI Key:  QJMNHMDXWLXDFS-UBPFNZRSSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 404.46

Molecular Weight (Monoisotopic): 404.1947

AlogP: 1.19

#Rotatable Bonds: 7

Polar Surface Area: 121.37

Molecular Species: NEUTRAL

HBA: 8

HBD: 3

#RO5 Violations: 0

HBA (Lipinski): 8

HBD (Lipinski): 3

#RO5 Violations (Lipinski): 0

CX Acidic pKa: 13.10

CX Basic pKa:

CX LogP: 0.20

CX LogD: 0.20

Aromatic Rings: 2

Heavy Atoms: 29

QED Weighted: 0.59

Np Likeness Score: 0.74

References

1. Brown P, Best DJ, Broom NJ, Cassels R, O'Hanlon PJ, Mitchell TJ, Osborne NF, Wilson JM..  (1997)  The chemistry of pseudomonic acid. 18. Heterocyclic replacement of the alpha,beta-unsaturated ester: synthesis, molecular modeling, and antibacterial activity.,  40  (16): [PMID:9258363] [10.1021/jm960738k]

Source

Source(1):

• Scientific Literature